Biocryst Pharmaceuticals (BCRX) Assets (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Assets came in at $465.1 million in Q1 2026, down 3.12% YoY from $480.0 million in Q1 2025, and down 9.55% on a QoQ basis from $514.2 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Assets (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 17 years of Assets data on file, last reported at $465.1 million in Q1 2026.
- Quarterly Assets fell 3.12% year-over-year to $465.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $465.1 million (down 3.12% YoY) and the FY2025 annual result came in at $514.2 million, up 4.84% from the prior year.
- Assets declined to $465.1 million in Q1 2026, from $514.2 million in the prior quarter.
- In the past five years, Assets ranged from a high of $558.6 million in Q3 2022 to a low of $446.4 million in Q3 2025.
- A 5-year average of $500.7 million and a median of $509.7 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets soared 110.19% — and 2024, when it retreated 10.84%.
- Tracing BCRX's Assets over 5 years: stood at $550.0 million in 2022, then decreased by 6.01% to $517.0 million in 2023, then fell by 5.13% to $490.4 million in 2024, then rose by 4.84% to $514.2 million in 2025, then dropped by 9.55% to $465.1 million in 2026.
- The last three Assets figures came in at $465.1 million (Q1 2026), $514.2 million (Q4 2025), and $446.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 6.18 Bn |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 557.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 557.85 Mn |
| Mar 31, 2026 | 465.05 Mn |
| Dec 31, 2025 | 514.16 Mn |
| Sep 30, 2025 | 446.42 Mn |
| Jun 30, 2025 | 457.19 Mn |
| Mar 31, 2025 | 480.05 Mn |
| Dec 31, 2024 | 490.42 Mn |
| Sep 30, 2024 | 491.25 Mn |
| Jun 30, 2024 | 472.42 Mn |
| Mar 31, 2024 | 467.89 Mn |
| Dec 31, 2023 | 516.96 Mn |
| Sep 30, 2023 | 522.92 Mn |
| Jun 30, 2023 | 529.89 Mn |
| Mar 31, 2023 | 509.74 Mn |
| Dec 31, 2022 | 550.00 Mn |
| Sep 30, 2022 | 558.59 Mn |
| Jun 30, 2022 | 510.54 Mn |
| Mar 31, 2022 | 527.72 Mn |
| Dec 31, 2021 | 588.15 Mn |
| Sep 30, 2021 | 265.76 Mn |